
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **SCGB1D2, SCGB2A2**: These are secretoglobins, small secreted proteins often associated with epithelial cells, particularly in the mammary gland.<br>- **IGFBP5**: Insulin-like growth factor binding protein 5, involved in cell growth and apoptosis, often expressed in epithelial cells.<br>- **HMGCS2**: Hydroxymethylglutaryl-CoA synthase 2, involved in ketogenesis, can be expressed in various tissues.<br>- **TFF3, TFF1**: Trefoil factors, involved in mucosal protection and repair, commonly expressed in epithelial tissues.<br>- **GFRA1**: GDNF family receptor alpha 1, involved in neuronal development but also expressed in some epithelial cells.<br>- **KRT19, KRT18**: Keratins, structural proteins in epithelial cells, particularly in simple epithelia.<br>- **MUC1**: Mucin 1, a glycoprotein expressed on the apical surface of epithelial cells, especially in glandular tissues.<br>- **XBP1**: X-box binding protein 1, involved in the unfolded protein response, expressed in secretory cells.<br>- **AZGP1**: Zinc-alpha-2-glycoprotein, involved in lipid metabolism, often expressed in epithelial cells.<br><br>### Step 2: List the Key Cell Type Markers<br>- **SCGB2A2 (Mammaglobin)**: Highly specific to mammary gland epithelial cells, often used as a marker for breast tissue.<br>- **KRT19, KRT18**: Commonly expressed in epithelial cells, particularly in the mammary gland.<br>- **MUC1**: Expressed in glandular epithelial cells, including those in the breast.<br>- **TFF1, TFF3**: Associated with epithelial cells in the gastrointestinal tract and breast tissue.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas and literature on breast tissue markers:<br>- **SCGB2A2** is a well-known marker for breast epithelial cells.<br>- **KRT19** and **KRT18** are markers for luminal epithelial cells in the breast.<br>- **MUC1** is a marker for luminal epithelial cells and is often overexpressed in breast cancer.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of markers like SCGB2A2, KRT19, KRT18, and MUC1, the most probable general cell type is **epithelial cells**, specifically those from the mammary gland.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Luminal Epithelial Cells**: High expression of SCGB2A2, KRT19, KRT18, and MUC1 strongly suggests luminal epithelial cells, which are the predominant cell type in the mammary gland.<br>2. **Luminal Progenitor Cells**: These cells also express KRT19 and KRT18 but may have a slightly different expression profile, including markers like IGFBP5.<br>3. **Basal/Myoepithelial Cells**: Although less likely due to the lack of specific basal markers, some overlap in keratin expression can occur.<br><br>**Most Likely Subtype**: **Luminal Epithelial Cells** are the most likely subtype given the strong expression of SCGB2A2, KRT19, KRT18, and MUC1.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset indicates that the cell cluster is most likely composed of epithelial cells, specifically luminal epithelial cells of the mammary gland. This conclusion is supported by the high expression of SCGB2A2, KRT19, KRT18, and MUC1, which are well-established markers for this cell type. The presence of other markers like TFF1 and TFF3 further supports this annotation.<br><br>**FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency**:<br>   - The key functional markers and cell type markers listed in the annotation (SCGB1D2, SCGB2A2, IGFBP5, HMGCS2, TFF3, TFF1, GFRA1, KRT19, KRT18, MUC1, XBP1, AZGP1) are all present in the provided marker list.<br>   - The markers SCGB2A2, KRT19, KRT18, and MUC1 are well-known markers for epithelial cells, particularly luminal epithelial cells in the mammary gland, which aligns with the annotation.<br><br>2. **Mixed Cell Type Consideration**:<br>   - The annotation considers the possibility of mixed cell types by identifying potential subtypes such as luminal epithelial cells, luminal progenitor cells, and basal/myoepithelial cells.<br>   - The strong expression of SCGB2A2, KRT19, KRT18, and MUC1 supports the identification of luminal epithelial cells as the predominant cell type, with no strong evidence of other distinct cell types requiring further investigation.<br><br>The annotation is well-supported by the marker list and the analysis provided, leading to a clear and justified conclusion of luminal epithelial cells as the most likely cell type.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Epithelial Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Luminal Epithelial Cells</li><li>Luminal Progenitor Cells</li><li>Basal/Myoepithelial Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a strong understanding of the marker list and its implications for identifying cell types within the context of human breast cancer. The analysis correctly identifies the main cell type as epithelial cells, with a specific focus on luminal epithelial cells, which is well-supported by the presence of key markers such as SCGB2A2, KRT19, KRT18, and MUC1. These markers are indeed highly indicative of luminal epithelial cells in the mammary gland, and their prominence in the list justifies the conclusion.<br><br>The annotation process shows a balanced consideration of multiple markers, not overly focusing on a single marker but rather integrating information from several key markers to form a comprehensive view. The inclusion of markers like TFF1, TFF3, and IGFBP5 further supports the epithelial nature of the cells and suggests a nuanced understanding of the potential subtypes present, such as luminal progenitor cells and basal/myoepithelial cells.<br><br>The analysis also demonstrates an awareness of the possibility of mixed cell types, although it concludes that the evidence strongly supports luminal epithelial cells as the predominant type. This is a reasonable conclusion given the marker list, and the annotation does not overlook any obvious markers that would suggest a different primary cell type.<br><br>One area for potential improvement could be a more explicit consideration of the rank of the markers, as markers appearing earlier in the list might carry more weight. However, the overall analysis does not seem to suffer significantly from this, as the key markers identified are indeed among the most relevant for the cell type in question.<br><br>Overall, the annotation is scientifically accurate, well-balanced, and provides a comprehensive view of the cell types present, with no obvious misclassifications or oversights.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    